The DOI matches its Crossref record; 61 of the 61 references it cites were found in a registry or an index.
Mismatch repair-dependent G2 checkpoint induced by low doses of SN1 type methylating agents requires the ATR kinase
Open accessAbstract
S N 1-type alkylating agents represent an important class of chemotherapeutics, but the molecular mechanisms underlying their cytotoxicity are unknown. Thus, although these substances modify predominantly purine nitrogen atoms, their toxicity appears to result from the processing of O6-methylguanine (6Me G)-containing mispairs by the mismatch repair (MMR) system, because cells with defective MMR are highly resistant to killing by these agents. In an attempt to understand the role of the MMR system in the molecular transactions underlying the toxicity of alkylating agents, we studied the response of human MMR-proficient and MMR-deficient cells to low concentrations of the prototypic methylating agent N-methyl-N′-nitro-N-nitrosoguanidine (MNNG). We now show that MNNG treatment induced a cell cycle arrest that was absolutely dependent on functional MMR. Unusually, the cells arrested only in the second G 2 phase after treatment. Downstream targets of both ATM (Ataxia telangiectasia mutated) and ATR (ATM and Rad3-related) kinases were modified, but only the ablation of ATR, or the inhibition of CHK1, attenuated the arrest. The checkpoint activation was accompanied by the formation of nuclear foci containing the signaling and repair proteins ATR, the S*/T*Q substrate, γ-H2AX, and replication protein A (RPA). The persistence of these foci implied that they may represent sites of irreparable damage.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“MLH1 is also required for MNNG-induced ATR checkpoint activation such as Chk1 phosphorylation and the colocalization of γ-H2AX and RPA [213]”
From Functional interplay between ATM/ATR-mediated DNA damage response and DNA repair pathways in oxidative stress (2014) · cites this paper as [213]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation
Bakkenist, C. J., & Kastan, M. B. (2003) · Nature · doi:10.1038/nature01368 · Cited by 3,466
Oxidative DNA damage: mechanisms, mutation, and disease
Cooke, M. S., Evans, M. D., Dizdaroglu, M., & Lunec, J. (2003) · The FASEB Journal · doi:10.1096/fj.02-0752rev · Cited by 3,245
Sensing DNA Damage Through ATRIP Recognition of RPA-ssDNA Complexes
Zou, L., & Elledge, S. J. (2003) · Science · doi:10.1126/science.1083430 · Cited by 2,693
ATM and related protein kinases: safeguarding genome integrity
Shiloh, Y. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1011 · Cited by 2,577
Megabase Chromatin Domains Involved in DNA Double-Strand Breaks in Vivo
Rogakou, E. P., Boon, C., Redon, C., & Bonner, W. M. (1999) · The Journal of Cell Biology · doi:10.1083/jcb.146.5.905 · Cited by 2,422
A critical role for histone H2AX in recruitment of repair factors to nuclear foci after DNA damage
Paull, T. T., Rogakou, E. P., Yamazaki, V., Kirchgessner, C. U., Gellert, M., & Bonner, W. M. (2000) · Current Biology · doi:10.1016/s0960-9822(00)00610-2 · Cited by 2,098
Cell cycle checkpoint signaling through the ATM and ATR kinases
Abraham, R. T. (2001) · Genes & Development · doi:10.1101/gad.914401 · Cited by 1,966
Liu, Q., Guntuku, S., Cui, X.-S., Matsuoka, S., Cortez, D., Tamai, K., Luo, G., Carattini-Rivera, S., DeMayo, F., Bradley, A., et al. (2000) · Genes & Development · doi:10.1101/gad.14.12.1448 · Cited by 1,625
The ATM-Chk2-Cdc25A checkpoint pathway guards against radioresistant DNA synthesis
Falck, J., Mailand, N., Syljuåsen, R. G., Bartek, J., & Lukas, J. (2001) · Nature · doi:10.1038/35071124 · Cited by 1,085
(1999) · PubMed · Cited by 1,030
Research works printed but not linked: 7
- 2000, Cancer Res., 60, 2108
- 2003, Cancer Res., 63, 8158
- 1995, Cancer Res., 55, 3721
- 1999, Cancer Res., 59, 4375
- 1997, Cancer Res., 57, 3949
- 2001, Cancer Res., 61, 8554
- 2003, Clin. Cancer Res., 9, 2327
Cited by
Sorted by citations
Mechanisms and functions of DNA mismatch repair
Li, G. (2007) · Cell Research · doi:10.1038/cr.2007.115 · Cited by 1,479
The multifaceted mismatch-repair system
Jiricny, J. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1907 · Cited by 1,375
Self-citationGenomic and Epigenetic Instability in Colorectal Cancer Pathogenesis
Grady, W. M., & Carethers, J. M. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.07.076 · Cited by 991
DNA Mismatch Repair: Functions and Mechanisms
Iyer, R. R., Pluciennik, A., Burdett, V., & Modrich, P. L. (2005) · Chemical Reviews · doi:10.1021/cr0404794 · Cited by 935
MGMT promoter methylation in malignant gliomas: ready for personalized medicine?
Weller, M., Stupp, R., Reifenberger, G., Brandes, A. A., van den Bent, M. J., Wick, W., & Hegi, M. E. (2009) · Nature Reviews Neurology · doi:10.1038/nrneurol.2009.197 · Cited by 803
The Histone Mark H3K36me3 Regulates Human DNA Mismatch Repair through Its Interaction with MutSα
Li, F., Mao, G., Tong, D., Huang, J., Gu, L., Yang, W., & Li, G. (2013) · Cell · doi:10.1016/j.cell.2013.03.025 · Cited by 622
Topoisomerase I poisoning results in PARP-mediated replication fork reversal
Chaudhuri, A. R., Hashimoto, Y., Herrador, R., Neelsen, K. J., Fachinetti, D., Bermejo, R., Cocito, A., Costanzo, V., & Lopes, M. (2012) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.2258 · Cited by 524
Karran, P., & Attard, N. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2292 · Cited by 477
Methylating Agents and DNA Repair Responses: Methylated Bases and Sources of Strand Breaks
Wyatt, M. D., & Pittman, D. L. (2006) · Chemical Research in Toxicology · doi:10.1021/tx060164e · Cited by 487
DNA mismatch repair: Molecular mechanism, cancer, and ageing
Hsieh, P., & Yamane, K. (2008) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2008.02.012 · Cited by 463
Mismatch repair and DNA damage signalling
Stojic, L., Brun, R., & Jiricny, J. (2004) · DNA Repair · doi:10.1016/j.dnarep.2004.06.006 · Cited by 396
Self-citationStructure of the Human MutSα DNA Lesion Recognition Complex
Warren, J. J., Pohlhaus, T. J., Changela, A., Iyer, R. R., Modrich, P. L., & Beese, L. S. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.04.018 · Cited by 361
ATR signalling: more than meeting at the fork
Nam, E. A., & Cortez, D. (2011) · Biochemical Journal · doi:10.1042/bj20102162 · Cited by 316
DNA mismatch repair and the DNA damage response
Li, Z., Pearlman, A. H., & Hsieh, P. (2015) · DNA repair · doi:10.1016/j.dnarep.2015.11.019 · Cited by 323
Triazene compounds: Mechanism of action and related DNA repair systems
Marchesi, F., Turriziani, M., Tortorelli, G., Avvisati, G., Torino, F., & Devecchis, L. (2007) · Pharmacological Research · doi:10.1016/j.phrs.2007.08.003 · Cited by 299
ATR Kinase Activation Mediated by MutSα and MutLα in Response to Cytotoxic O6-Methylguanine Adducts
Yoshioka, K.-I., Yoshioka, Y., & Hsieh, P. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.04.023 · Cited by 288
Taketo, M. M., & Edelmann, W. (2009) · Gastroenterology · doi:10.1053/j.gastro.2008.12.049 · Cited by 257
Yan, S., Sorrell, M., & Berman, Z. (2014) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-014-1666-4 · Cited by 247
Christmann, M., Verbeek, B., Roos, W. P., & Kaina, B. (2011) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2011.06.002 · Cited by 242
Does γH2AX foci formation depend on the presence of DNA double strand breaks?
Takahashi, A., & Ohnishi, T. (2005) · Cancer Letters · doi:10.1016/j.canlet.2005.07.016 · Cited by 205
Signalling cell cycle arrest and cell death through the MMR System
O’Brien, V., & Brown, R. E. (2005) · Carcinogenesis · doi:10.1093/carcin/bgi298 · Cited by 203
Mojaš, N., Lopes, M., & Jiricny, J. (2007) · Genes & Development · doi:10.1101/gad.455407 · Cited by 189
Self-citationResidual γH2AX foci as an indication of lethal DNA lesions
Banáth, J. P., Klokov, D. Y., MacPhail, S. H., Banuelos, C. A., & Olive, P. L. (2010) · BMC Cancer · doi:10.1186/1471-2407-10-4 · Cited by 186
Thiopurines, DNA damage, DNA repair and therapy-related cancer
Karran, P. (2006) · British Medical Bulletin · doi:10.1093/bmb/ldl020 · Cited by 182
Molecular pathology of Lynch syndrome
Cerretelli, G., Ager, A., Arends, M. J., & Frayling, I. M. (2020) · The Journal of Pathology · doi:10.1002/path.5422 · Cited by 179
Characterization of the Interactome of the Human MutL Homologues MLH1, PMS1, and PMS2
Cannavò, E., Gerrits, B., Marra, G., Schlapbach, R., & Jiricny, J. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m609989200 · Cited by 158
Self-citationRegulation of NF‐κB and p53 through activation of ATR and Chk1 by the ARF tumour suppressor
Rocha, S., Garrett, M. D., Campbell, K. J., Schumm, K., & Perkins, N. D. (2005) · The EMBO Journal · doi:10.1038/sj.emboj.7600608 · Cited by 161
Surgical resection of malignant gliomas—role in optimizing patient outcome
Eyüpoglu, I. Y., Buchfelder, M., & Savaskan, N. E. (2013) · Nature Reviews Neurology · doi:10.1038/nrneurol.2012.279 · Cited by 166
Noncanonical Mismatch Repair as a Source of Genomic Instability in Human Cells
Peña-Dı́az, J., Bregenhorn, S., Ghodgaonkar, M. M., Follonier, C., Borán, M. S., Castor, D., Lopes, M., Sartori, A. A., & Jiricny, J. (2012) · Molecular Cell · doi:10.1016/j.molcel.2012.07.006 · Cited by 150
Self-citationDNA repair in personalized brain cancer therapy with temozolomide and nitrosoureas
Kaina, B., & Christmann, M. (2019) · DNA repair · doi:10.1016/j.dnarep.2019.04.007 · Cited by 147
Nuclear factor-κB in glioblastoma: insights into regulators and targeted therapy
Cahill, K. E., Morshed, R. A., & Yamini, B. (2015) · Neuro-Oncology · doi:10.1093/neuonc/nov265 · Cited by 144
Edelbrock, M. A., Saravanan, K., & Williams, K. J. (2013) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2012.12.008 · Cited by 149
Tsesmetzis, N., Paulin, C. B. J., Rudd, S. G., & Herold, N. (2018) · Cancers · doi:10.3390/cancers10070240 · Cited by 140
Reynolds, M., Stoddard, L., Bespalov, I. A., & Zhitkovich, A. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkl1069 · Cited by 138
Noncanonical Mismatch Repair as a Source of Genomic Instability in Human Cells
Peña-Dı́az, J., Bregenhorn, S., Ghodgaonkar, M. M., Follonier, C., Borán, M. S., Castor, D., Lopes, M., Sartori, A. A., & Jiricny, J. (2017) · Molecular Cell · doi:10.1016/j.molcel.2017.06.026 · Cited by 132
Self-citationMismatch Repair Proteins Are Activators of Toxic Responses to Chromium-DNA Damage
Peterson-Roth, E., Reynolds, M., Quievryn, G., & Zhitkovich, A. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.9.3596-3607.2005 · Cited by 133
Yoshimoto, K., Mizoguchi, M., Hata, N., Murata, H., Hatae, R., Amano, T., Nakamizo, A., & Sasaki, T. (2012) · Frontiers in Oncology · doi:10.3389/fonc.2012.00186 · Cited by 126
NUDT15 Hydrolyzes 6-Thio-DeoxyGTP to Mediate the Anticancer Efficacy of 6-Thioguanine
Valerie, N. C. K., Hagenkort, A., Page, B. D. G., Masuyer, G., Rehling, D., Carter, M., Bevc, L., Herr, P., Homan, E. J., Gustafsson, N., et al. (2016) · Cancer Research · doi:10.1158/0008-5472.can-16-0584 · Cited by 125
Teodoridis, J. M., Strathdee, G. R., & Brown, R. E. (2004) · Drug Resistance Updates · doi:10.1016/j.drup.2004.06.005 · Cited by 124
Eich, M., Roos, W. P., Nikolova, T., & Kaina, B. (2013) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-13-0136 · Cited by 124
Hsu, J., Hsu, I., Xu, D., Miyamoto, H., Liang, L., Wu, X., Shyr, C., & Chang, C. (2013) · American Journal Of Pathology · doi:10.1016/j.ajpath.2013.01.018 · Cited by 118
Structure and function of the components of the human DNA mismatch repair system
Jascur, T. A., & Boland, C. R. (2006) · International Journal of Cancer · doi:10.1002/ijc.22023 · Cited by 119
HIV-1 Vpr-Induced Apoptosis Is Cell Cycle Dependent and Requires Bax but Not ANT
Andersen, J. L., DeHart, J. L., Zimmerman, E. S., Ardon, O., Kim, B., Jacquot, G., Bénichou, S., & Planelles, V. (2006) · PLoS Pathogens · doi:10.1371/journal.ppat.0020127 · Cited by 120
Dependence of the Cytotoxicity of DNA-Damaging Agents on the Mismatch Repair Status of Human Cells
Papouli, E., Ćejka, P., & Jiricny, J. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0513 · Cited by 116
Self-citationThe mismatch repair-dependent DNA damage response: Mechanisms and implications
Gupta, D., & Heinen, C. D. (2019) · DNA repair · doi:10.1016/j.dnarep.2019.03.009 · Cited by 117
5-Fluorouracil Is Efficiently Removed From DNA by the Base Excision and Mismatch Repair Systems
Fischer, F., Baerenfaller, K., & Jiricny, J. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.09.003 · Cited by 116
Self-citationThe γ‐H2A.X: Is it just a surrogate marker of double‐strand breaks or much more?
Ismail, I. H., & Hendzel, M. J. (2007) · Environmental and Molecular Mutagenesis · doi:10.1002/em.20358 · Cited by 114
Jun, S., Kim, T., & Ban, C. (2006) · FEBS Journal · doi:10.1111/j.1742-4658.2006.05190.x · Cited by 107
Roos, W. P., Nikolova, T., Quirós, S., Naumann, S. C., Kiedron, O., Zdzienicka, M. Z., & Kaina, B. (2008) · DNA repair · doi:10.1016/j.dnarep.2008.09.003 · Cited by 106
Kunz, C., Saito, Y., & Schär, P. (2009) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-009-8739-9 · Cited by 104
Naumann, S. C., Roos, W. P., Jöst, E., Belohlavek, C., Lennerz, V., Schmidt, C., Christmann, M., & Kaina, B. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6604856 · Cited by 101
DNA double-strand breaks: Their production, recognition, and repair in eukaryotes
Ohnishi, T., Mori, E., & Takahashi, A. (2009) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/j.mrfmmm.2009.06.010 · Cited by 98
York, S. J., & Modrich, P. L. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m603667200 · Cited by 98
Checkpoint mechanisms at the intersection between DNA damage and repair
Lazzaro, F., Giannattasio, M., Puddu, F., Granata, M., Pellicioli, A., Plevani, P., & Muzi-Falconi, M. (2009) · DNA Repair · doi:10.1016/j.dnarep.2009.04.022 · Cited by 94
Rapid DNA Double-Strand Breaks Resulting from Processing of Cr-DNA Cross-Links by Both MutS Dimers
Reynolds, M., Peterson-Roth, E., Bespalov, I. A., Johnston, T., Gurel, V., Menard, H. L., & Zhitkovich, A. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-2306 · Cited by 90
Morales, M., Theunissen, J.-W. F., Kim, C. F. B., Kitagawa, R., Kastan, M. B., & Petrini, J. H. J. (2005) · Genes & Development · doi:10.1101/gad.1373705 · Cited by 87
Methylator-induced, Mismatch Repair-dependent G2Arrest Is Activated through Chk1 and Chk2
Adamson, A. W., Beardsley, D. I., Kim, W.-J., Gao, Y., Baskaran, R., & Brown, K. D. (2005) · Molecular Biology of the Cell · doi:10.1091/mbc.e04-02-0089 · Cited by 89
Katsube, T., Mori, M., Tsuji, H., Shiomi, T., Wang, B., Liu, Q., Nenoi, M., & Onoda, M. (2014) · The Journal of Biochemistry · doi:10.1093/jb/mvu021 · Cited by 94
Chemotherapeutic implications in microsatellite unstable colorectal cancer1
Jo, W., & Carethers, J. M. (2006) · Cancer Biomarkers · doi:10.3233/cbm-2006-21-206 · Cited by 87
Shinsato, Y., Furukawa, T., Yunoue, S., Yonezawa, H., Minami, K., Nishizawa, Y., Ikeda, R., Kawahara, K., Yamamoto, M., Hirano, H., et al. (2013) · Oncotarget · doi:10.18632/oncotarget.1302 · Cited by 81
Caporali, S., Levati, L., Starace, G., Ragone, G., Bonmassar, E., Alvino, E., & D’Atri, S. (2008) · Molecular Pharmacology · doi:10.1124/mol.107.044743 · Cited by 80
Mismatch Repair Protein Deficiency Compromises Cisplatin-induced Apoptotic Signaling
Topping, R. P., Wilkinson, J. C., & Scarpinato, K. D. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m809303200 · Cited by 79
Interactions of Human Mismatch Repair Proteins MutSα and MutLα with Proteins of the ATR-Chk1 Pathway
Liu, Y., Fang, Y., Shao, H., Lindsey-Boltz, L., Sancar, A., & Modrich, P. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.076109 · Cited by 78
Pascucci, B. (2005) · Nucleic Acids Research · doi:10.1093/nar/gki168 · Cited by 77
Aberrations in DNA repair pathways in cancer and therapeutic significances
Motegi, A., Masutani, M., Yoshioka, K., & Bessho, T. (2019) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.02.005 · Cited by 76
Loughery, J., Dunne, P. D., O’Neill, K. M., Meehan, R. R., McDaid, J. R., & Walsh, C. P. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr236 · Cited by 76
Genotype to phenotype: Analyzing the effects of inherited mutations in colorectal cancer families
Heinen, C. D. (2009) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2009.09.004 · Cited by 67
Pituitary Carcinoma in a Patient with an SDHB Mutation
Tufton, N., Roncaroli, F., Hadjidemetriou, I., Dang, M. N., Dénes, J., Guasti, L., Thom, M., Powell, M. P., Baldeweg, S. E., Fersht, N. L., et al. (2017) · Endocrine Pathology · doi:10.1007/s12022-017-9474-7 · Cited by 62
DNA Double-Strand Breaks after Percutaneous Transluminal Angioplasty
Geisel, D., Heverhagen, J. T., Kalinowski, M., & Wagner, H. (2008) · Radiology · doi:10.1148/radiol.2483071686 · Cited by 58
Wu, Q., & Vásquez, K. M. (2008) · PLoS Genetics · doi:10.1371/journal.pgen.1000189 · Cited by 60
Degradation of Human Exonuclease 1b upon DNA Synthesis Inhibition
El‐Shemerly, M., Janščák, P., Heß, D., Jiricny, J., & Ferrari, S. M. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-4069 · Cited by 59
Self-citationMolecular and Cellular Mechanisms of Hexavalent Chromium-Induced Lung Cancer: An Updated Perspective
Urbano, A. M., Ferreira, L. M. R., & Alpoim, M. C. (2012) · Current Drug Metabolism · doi:10.2174/138920012799320464 · Cited by 59
The cell cycle and DNA mismatch repair
Schroering, A. G., Edelbrock, M. A., Richards, T. J., & Williams, K. J. (2006) · Experimental Cell Research · doi:10.1016/j.yexcr.2006.10.018 · Cited by 56
Gao, H., Coyle, D. L., Meyer‐Ficca, M. L., Meyer, R. G., Jacobson, E. L., Wang, Z., & Jacobson, M. K. (2007) · Experimental Cell Research · doi:10.1016/j.yexcr.2006.12.025 · Cited by 58
Qi, Y., Schoene, N. W., Lartey, F. M., & Cheng, W.-H. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.137406 · Cited by 57
Epigenetic Deregulation of DNA Repair and Its Potential for Therapy
Hegi, M. E., Sciuscio, D., Murat, A., Levivier, M., & Stupp, R. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-1169 · Cited by 57
Bendich, A. J. (2007) · BioEssays · doi:10.1002/bies.20576 · Cited by 56
Cell cycle-dependent DNA damage signaling induced by ICRF-193 involves ATM, ATR, CHK2, and BRCA1
Park, I., & Avraham, H. K. (2006) · Experimental Cell Research · doi:10.1016/j.yexcr.2006.02.029 · Cited by 56
Therapeutic modulation of epigenetic drivers of drug resistance in ovarian cancer
Zeller, C., & Brown, R. E. (2010) · Therapeutic Advances in Medical Oncology · doi:10.1177/1758834010375759 · Cited by 56
Targeting and processing of site‐specific DNA interstrand crosslinks
Vásquez, K. M. (2010) · Environmental and Molecular Mutagenesis · doi:10.1002/em.20557 · Cited by 53
p50 (NF-κB1) Is an Effector Protein in the Cytotoxic Response to DNA Methylation Damage
Schmitt, A. M., Crawley, C. D., Kang, S., Raleigh, D. R., Yu, X., Wahlstrom, J. S., Voce, D. J., Darga, T. E., Weichselbaum, R. R., & Yamini, B. (2011) · Molecular Cell · doi:10.1016/j.molcel.2011.09.026 · Cited by 53
Homologous recombination is involved in repair of chromium-induced DNA damage in mammalian cells
Bryant, H. E., Ying, S., & Helleday, T. (2006) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2006.02.001 · Cited by 53
DNA Mismatch Repair Proteins Are Required for Efficient Herpes Simplex Virus 1 Replication
Mohni, K. N., Mastrocola, A. S., Bai, P., Weller, S. K., & Heinen, C. D. (2011) · Journal of Virology · doi:10.1128/jvi.05487-11 · Cited by 52
Klapacz, J., Pottenger, L. H., Engelward, B. P., Heinen, C. D., Johnson, G. E., Clewell, R. A., Carmichael, P. L., Adeleye, Y. A., & Andersen, M. E. (2015) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2015.11.001 · Cited by 52
Girard, P.-M., Pozzebon, M. E., Delacôte, F., Douki, T., Smirnova, V., & Sage, É. (2008) · DNA repair · doi:10.1016/j.dnarep.2008.05.004 · Cited by 57
ASCIZ regulates lesion‐specific Rad51 focus formation and apoptosis after methylating DNA damage
McNees, C. J., Conlan, L. A., Tenis, N., & Heierhorst, J. (2005) · The EMBO Journal · doi:10.1038/sj.emboj.7600704 · Cited by 52
The mismatch repair‐mediated cell cycle checkpoint response to fluorodeoxyuridine
Liu, A., Yoshioka, K., Salerno, V., & Hsieh, P. (2008) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21824 · Cited by 50
Su, X., Bernal, J. A., & Venkitaraman, A. R. (2008) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1490 · Cited by 49
Kinetics of γ‐H2AX focus formation upon treatment of cells with UV light and alkylating agents
Staszewski, O., Nikolova, T., & Kaina, B. (2008) · Environmental and Molecular Mutagenesis · doi:10.1002/em.20430 · Cited by 49
Mismatch Repair Status and the Response of Human Cells to Cisplatin
Pani, E., Stojic, L., El‐Shemerly, M., Jiricny, J., & Ferrari, S. M. (2007) · Cell Cycle · doi:10.4161/cc.6.14.4472 · Cited by 47
Self-citationZecevic, A., Menard, H. L., Gurel, V., Hagan, E., DeCaro, R., & Zhitkovich, A. (2009) · Cell Cycle · doi:10.4161/cc.8.17.9410 · Cited by 44
Distinct effects of the recurrent Mlh1 G67R mutation on MMR functions, cancer, and meiosis
Avdievich, E., Reiß, C., Scherer, S. J., Zhang, Y., Maier, S. M., Jin, B., Hou, H., Rosenwald, A., Riedmiller, H. N., Kucherlapati, R., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0800276105 · Cited by 44
Kim, J., Kim, J. Y., Kim, J., Kim, S., Chung, H., & Park, C. (2014) · Genes & Cancer · doi:10.18632/genesandcancer.16 · Cited by 43
Noonan, E. M., Shah, D., Yaffe, M. B., Lauffenburger, D. A., & Samson, L. D. (2012) · Integrative Biology · doi:10.1039/c2ib20091k · Cited by 41
DNA Damage Response and Repair: Insights Into Strategies for Radiation Sensitization of Gliomas
Kesari, S., Advani, S. J., Lawson, J. D., Kahle, K. T., Ng, K., Carter, B. S., & Chen, C. C. (2011) · Future Oncology · doi:10.2217/fon.11.111 · Cited by 41
Fortini, P., Ferretti, C., Pascucci, B., Narciso, L., Pajalunga, D., Puggioni, E. M. R., Castino, R., Isidoro, C., Crescenzi, M., & Dogliotti, E. (2012) · Cell Death and Differentiation · doi:10.1038/cdd.2012.53 · Cited by 44
Mouse models of DNA mismatch repair in cancer research
Lee, K., Tosti, E., & Edelmann, W. (2015) · DNA repair · doi:10.1016/j.dnarep.2015.11.015 · Cited by 42
Caporali, S., Levati, L., Graziani, G., Muzi, A., Atzori, M. G., Bonmassar, E., Palmieri, G., Ascierto, P. A., & D’Atri, S. (2012) · Journal of Translational Medicine · doi:10.1186/1479-5876-10-252 · Cited by 40
Interaction between PARP-1 and ATR in mouse fibroblasts is blocked by PARP inhibition
Kedar, P. S., Stefanick, D. F., Horton, J. K., & Wilson, S. H. (2008) · DNA repair · doi:10.1016/j.dnarep.2008.07.006 · Cited by 45
Rapid induction of chromatin-associated DNA mismatch repair proteins after MNNG treatment
Schroering, A. G., & Williams, K. J. (2008) · DNA repair · doi:10.1016/j.dnarep.2008.03.023 · Cited by 39
Metadata
- Authors
- Stojic, L., Mojas, N., Cejka, P., di Pietro, M., Ferrari, S., Marra, G., & Jiricny, J.
- Affiliations
- University of Zurich (CH)
- Venue
- Genes & Development
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 2004-06-01
- Volume
- 18
- Issue
- 11
- Pages
- 1331-1344
- ISSN
- 0890-9369 (ISSN-L)
- 1549-5477
- PMC
- PMC420358
- OpenAlex
- W2127970987
- Cited by
- 246
- References
- 61
- Citations by year
- 2026: 6 · 2025: 4 · 2024: 8 · 2022: 5 · 2021: 4 · 2020: 6 · 2019: 7 · 2018: 3 · 2017: 7 · 2016: 7 · 2015: 7 · 2014: 17 · 2013: 14 · 2012: 14
- Type
- posted content
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- public-domain
- Locations
- Genes & Development (publishedVersion, public-domain)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Zurich Open Repository and Archive (University of Zurich) (acceptedVersion, other-oa)
- Zurich Open Repository and Archive (University of Zurich) (submittedVersion, other-oa)
- Zurich Open Repository and Archive (University of Zurich)
- Funders
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (064650)
- National Institutes of Health
- National Cancer Institute
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Health Sciences › Medicine › Pathology and Forensic Medicine › Genetic factors in colorectal cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Chromatin Remodeling and Cancer
- Keywords
- DNA mismatch repair, G2 checkpoint, ATR kinase, N-methyl-N'-nitro-N-nitrosoguanidine, O6-methylguanine, cell cycle arrest, ATM kinase, Chk1, γH2AX, replication protein A, DNA repair
- MeSH terms
- Checkpoint Kinase 1, Caffeine, Cell Cycle, Cell Line, DNA, DNA Damage, DNA Repair, DNA-Binding Proteins, Dose-Response Relationship, Drug, Enzyme Inhibitors, Histones, Humans, Methylation, Methylnitronitrosoguanidine, Phosphorylation, Protein Kinases, Signal Transduction, G2 Phase, Protein Serine-Threonine Kinases, Cell Cycle Proteins, Staurosporine, Base Pair Mismatch, Tumor Suppressor Proteins, Protein Kinase Inhibitors, Replication Protein A, Ataxia Telangiectasia Mutated Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review